Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences

被引:97
作者
Wang, XS
Lee, S
Simmons, Z
Boyer, P
Scott, K
Liu, WL
Connor, J
机构
[1] Penn State Coll Med, GM Leader Family Lab Alzheimers Dis Res, Dept Neurosurg H110, Hershey, PA 17033 USA
[2] Penn State Coll Med, Dept Neurol, Hershey, PA 17033 USA
[3] SW Texas State Univ, Dept Pathol, Div Neuropathol, Dallas, TX 75390 USA
[4] SW Texas State Univ, Dept Hlth Evaluat Sci, Dallas, TX 75390 USA
关键词
oxidative stress; iron; Hfe mutation; SOD1;
D O I
10.1016/j.jns.2004.08.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The etiology of amyotrophic lateral sclerosis (ALS) is unknown. The presence of mutations in the superoxide dismutase gene (SOD I) has led to theories regarding a role for oxidative stress in the pathogenesis of this disease. A primary cause of oxidative stress is perturbations in cellular iron homeostasis. Cellular iron mismanagement and oxidative stress are associated with a number of neurodegenerative diseases. One mechanism by which cells fail to properly regulate their iron status is through a mutation in the We gene. Mutations in the We gene are associated with the iron overload disease, hemochromatosis. In the current study, 31% of patients with sporadic ALS carried a mutation in the Hfe gene, compared to only 14% of patients without identifiable neuromuscular disease, or with neuromuscular diseases other than ALS (p<0.005). To determine the cellular consequences of carrying an Hfe mutation, a human neuronal cell line was transfected with genes carrying the Hfe mutation. The presence of the We mutation disrupted expression of tubulin and actin at the protein levels potentially consistent with the disruption of axonal transport seen in ALS and was also associated with a decrease in CuZnSOD1 expression. These data provide compelling evidence for a role for the Hfe mutation in etiopathogenesis of ALS and warrant further investigation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 36 条
[1]  
Anderson B, 2001, J BAND RES, V37, P1
[2]   OXYGEN FREE-RADICALS AND HUMAN-DISEASES [J].
ARUOMA, OI ;
KAUR, H ;
HALLIWELL, B .
JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1991, 111 (05) :172-177
[3]   Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis [J].
Bastin, JM ;
Jones, M ;
O'Callaghan, CA ;
Schimanski, L ;
Mason, DY ;
Townsend, ARM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :931-941
[4]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299
[5]   ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions [J].
Bruijn, LI ;
Becher, MW ;
Lee, MK ;
Anderson, KL ;
Jenkins, NA ;
Copeland, NG ;
Sisodia, SS ;
Rothstein, JD ;
Borchelt, DR ;
Price, DL ;
Cleveland, DW .
NEURON, 1997, 18 (02) :327-338
[6]   Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease [J].
Combarros, O ;
García-Román, M ;
Fontalba, A ;
Fernández-Luna, JL ;
Llorca, J ;
Infante, J ;
Berciano, J .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 15 (03) :151-154
[7]   Is hemochromatosis a risk factor for Alzheimer's disease? [J].
Connor, J. R. ;
Milward, E. A. ;
Moalem, S. ;
Sampietro, M. ;
Boyer, P. ;
Percy, M. E. ;
Vergani, C. ;
Scott, R. J. ;
Chorney, M. .
JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (05) :471-477
[8]   Cellular management of iron in the brain [J].
Connor, JR ;
Menzies, SL .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 :33-44
[9]  
Cookson MR, 1999, BRAIN PATHOL, V9, P165
[10]   Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces an iron-deficient phenotype [J].
Corsi, B ;
Levi, S ;
Cozzi, A ;
Corti, A ;
Altimare, D ;
Albertini, A ;
Arosio, P .
FEBS LETTERS, 1999, 460 (01) :149-152